The Future Of Brain-Computer Interfaces with Science’s Max Hodak (53 min)
ai-driven-innovation-economy ai-for-personalized-medicine ai-human-identity ai-in-aging-elder-care ai-in-everyday-life ai-singularity-speculation post-work-ai-society transhumanism-ai-enhancement
- Release date: 2026-03-09
- Listen on Spotify: Open episode
- Episode description:
YC alum Max Hodak is the co-founder of Neuralink and founder of Science, a company building brain-computer interfaces that can restore sight.Science has developed a tiny retinal implant that stimulates cells in the eye to help blind patients see again. More than 40 patients have already received the treatment in clinical trials, including one who recently read a full novel for the first time in over a decade.In this episode of How to Build the Future, Max joined Garry to discuss how BCIs work, what it takes to engineer the brain, and why brain-computer interfaces may become one of the most important technologies of the next decade.
Summary
- 👁️ Vision Restoration Breakthrough: Science’s Prima implant restores form vision to blind patients by stimulating retinal bipolar cells with laser-projected images, achieving eye-chart reading after decades of sight loss in a landmark trial.
- 🧠 Adult Brain Plasticity: The brain adapts rapidly under feedback in adulthood, enabling BCI control and distinguishing real percepts, far beyond critical early periods, with psychedelics potentially enhancing this.
- 🔬 Neural Engineering Shift: BCIs bypass drug discovery failures by directly interfacing brain APIs, outperforming in restoring senses like vision where therapies failed, reframing medicine.
- 🌐 Biohybrid Neural Links: Grafted engineered neurons form biological high-bandwidth connections, like Avatar’s ponytails, avoiding wires and enabling brain-to-brain interfaces without genetic modification.
- ♾️ Longevity Takeoff Era: BCI/AI convergence signals exponential biotech progress, potentially allowing today’s people to live 1,000 years by restoring functions and enhancing human capabilities.
Insights
Are we entering a ‘takeoff era’ where BCIs and AI propel humanity toward 1,000-year lifespans?
Time: 0:00 – 52:40
Category: Transhumanism & AI Enhancement, AI Singularity Speculation, AI in Aging & Elder CareAnswer: Biotech is shifting from incremental to exponential progress, with BCIs restoring senses/motor function and AI providing intelligence, potentially reframing aging and disease by 2035. Speaker predicts many alive today could reach 1,000, driven by parallel BCI/AI advances creating new human capabilities beyond curing diseases. (Start at 0:00)
Could a tiny retinal implant truly restore meaningful vision to those blind for decades?
Time: 1:03 – 17:42
Category: AI for Personalized Medicine, AI in Aging & Elder CareAnswer: Science’s Prima device, a 2mm silicon chip under the retina, uses laser-projected images to stimulate bipolar cells, bypassing dead photoreceptors, enabling patients to read eye charts after years of blindness as shown in a major clinical trial published in the New England Journal of Medicine. This marks the first achievement of form vision, creating coherent images rather than mere flashes, revolutionizing treatment for conditions like macular degeneration affecting millions. (Start at 1:03)
Is the human brain far more plastic in adulthood than commonly believed?
Time: 6:10 – 9:17
Category: AI & Human Identity, Transhumanism & AI EnhancementAnswer: The brain remains highly adaptable under feedback, allowing patients to quickly learn to control individual neurons via visual cues during surgery and adapt to BCI signals for motor control. Critical periods exist in early development, but adult plasticity enables learning new representations, challenging assumptions and opening doors for BCI applications beyond the young. (Start at 6:10)
Why might neural engineering outperform drug discovery in treating brain-related diseases?
Time: 13:31 – 15:08
Category: AI-Driven Innovation Economy, AI for Personalized MedicineAnswer: Drugs often fail after decades of research due to biological complexity, while BCIs like retinal prostheses directly restore signals at well-defined neural interfaces, achieving results like vision recovery where million-dollar gene therapies fell short. This paradigm shift reframes medicine by leveraging the brain’s computational power empirically better than chemical interventions. (Start at 13:31)
What if BCIs evolve into biohybrid ‘neural ponytails’ like in Avatar for ultra-high bandwidth connections?
Time: 29:32 – 32:23
Category: Transhumanism & AI Enhancement, AI & Human IdentityAnswer: Science’s biohybrid interfaces use hypoimmunogenic stem cell-derived neurons grafted onto the brain, forming biological connections without wires or gene therapy, mimicking nature’s corpus callosum for potential brain-to-brain or brain-to-machine links. This avoids immune rejection and enables growth across the brain, promising revolutionary input/output beyond electrical stimulation. (Start at 29:32)
Are AI latent spaces mirroring brain representations, unifying AI and neuroscience?
Time: 33:39 – 36:46
Category: AI in Everyday Life, AI Singularity SpeculationAnswer: Neural activity in the brain forms latent spaces akin to those in AI models, with concrete representations near inputs/outputs evolving into abstract manifolds deeper in, like object or face maps; AI models replicate these, validating AI approaches and aiding BCI decoding. This convergence accelerates understanding brain processing for advanced interfaces. (Start at 33:39)
Could portable perfusion devices make ‘brain-in-a-vat’ longevity feasible at home?
Time: 39:44 – 44:18
Category: AI in Aging & Elder Care, Post-Work AI SocietyAnswer: Current ECMO/heart-lung machines keep patients alive indefinitely in ICUs but raise ethical dilemmas due to cost and quality of life; Science’s Vessel aims to miniaturize them for home use, like backpack portability, enabling destination therapy and transforming organ transplants or end-of-life care. This bridges technical possibility with economic viability. (Start at 39:44)